SCHEMBL10222825

SCHEMBL10222825

O=S(=O)(/N=C/c1ccccc1)c1ccc(CBr)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ CA2 P00918 7/20 0.48
▸ CA1 P00915 5/20 0.47
▸ CA12 O43570 4/20 0.46
▸ CA9 Q16790 4/20 0.46
▸ LMNA P02545 1/20 0.44
▸ POLB P06746 2/20 0.43
▸ TRPA1 O75762 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PTGS2 P35354 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ CES2 O00748 1/20 0.39
▸ CES1 P23141 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21939418 0.84 ALDH1A1 (0.55) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL1933484 0.82 ALDH1A1 (0.69) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL984789 0.82 ALDH1A1 (0.69) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL12699925 0.82 ALDH1A1 (0.69) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL24192388 0.81 ALDH1A1 (0.55) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL1573970 0.81 ALDH1A1 (0.49) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL1517596 0.78 ALDH1A1 (0.55) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL1933186 0.78 ALDH1A1 (0.67) ALDH1A1KMT2ACA2CA12CA9
SCHEMBL1932741 0.78 ALDH1A1 (0.55) ALDH1A1KMT2ACA2CA1CA12
SCHEMBL1932739 0.78 ALDH1A1 (0.55) ALDH1A1KMT2ACA2CA1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524947-B2 Acylsulfonamides and processes for producing the same UNIVERSITY OF SOUTH FLORIDA (US) 2013-09-03 — — US disclosed
US-8524947-B2 Acylsulfonamides and processes for producing the same UNIVERSITY OF SOUTH FLORIDA (US) 2013-09-03 — — US disclosed
US-20130203709-A1 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME THE PENN STATE RESEARCH FOUNDATION (US) 2013-08-08 — — US disclosed
US-20130203709-A1 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME THE PENN STATE RESEARCH FOUNDATION (US) 2013-08-08 — — US disclosed
WO-2012021486-A2 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-16 — — WO disclosed
US-20110130568-A1 Acylsulfonamides and Processes for Producing the Same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-06-02 — — US disclosed
US-20110130568-A1 Acylsulfonamides and Processes for Producing the Same NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2011-06-02 — — US disclosed
WO-2009105751-A1 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME UNIVERSITY OF SOUTH FLORIDA (US) 2009-08-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130568-A1 Acylsulfonamides and Processes for Producing the Same BCL2, BCL2L2, BCL6 ALDH1A1 3847/4885KMT2A 1022/4885CA2 1346/4885
US-20130203709-A1 ACYLSULFONAMIDES AND PROCESSES FOR PRODUCING THE SAME BCL2, BCL2L2, BCL6 ALDH1A1 3847/4885KMT2A 1022/4885CA2 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback